News Adaptive Biotechnologies Corporation

Equities

ADPT

US00650F1093

Real-time Estimate Cboe BZX Other stock markets 10:10:25 2024-05-09 am EDT			5-day change	1st Jan Change
3.325 ^USD	+4.56%		+9.90%	-34.29%

May. 07	Earnings Flash (ADPT) ADAPTIVE BIOTECHNOLOGIES Reports Q1 Revenue $41.9M, vs. Street Est of $38.8M	MT
May. 07	Adaptive Biotechnologies Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (ADPT) ADAPTIVE BIOTECHNOLOGIES Reports Q1 Revenue $41.9M, vs. Street Est of $38.8M	May. 07	MT
Adaptive Biotechnologies: Q1 Earnings Snapshot	May. 07	AQ
Adaptive Biotechnologies Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07	CI
Transcript : Adaptive Biotechnologies Corporation, Q1 2024 Earnings Call, May 07, 2024	May. 07
Adaptive Biotechnologies Reports First Quarter 2024 Financial Results	May. 07	GL
Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024	Apr. 17	GL
Adaptive Biotechnologies Corporation Announces Preliminary Unaudited Revenue Results for the First Quarter Ended March 31, 2024	Apr. 05	CI
Adaptive Biotechnologies Corporation Announces CFO Changes	Apr. 02	CI
Adaptive Biotechnologies Reports Preliminary Q1 Revenue, Appoints Kyle Piskel as CFO	Apr. 02	MT
Transcript : Adaptive Biotechnologies Corporation - Special Call	Apr. 02
Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue	Apr. 02	GL
Adaptive Biotechnologies Corporation Provides Revenue Guidance for the First Quarter Ended March 31, 2024	Apr. 02	CI
Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024	Mar. 27	GL
Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024	Mar. 27	AQ
Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference	Feb. 22	GL
Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference	Feb. 22	AQ
JPMorgan Adjusts Price Target on Adaptive Biotechnologies to $8 From $11, Maintains Overweight Rating	Feb. 15	MT
Adaptive Biotechnologies' Q4 Loss Widens; Revenue Declines; Shares Down	Feb. 15	MT
Adaptive Biotechnologies: Q4 Earnings Snapshot	Feb. 14	AQ
Transcript : Adaptive Biotechnologies Corporation, Q4 2023 Earnings Call, Feb 14, 2024	Feb. 14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Adaptive Biotechnologies Corporation

Equities

ADPT

US00650F1093

Summary

Filters